Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers.

Lead inhibition of the zinc metalloenzyme delta-aminolevulinate dehydratase (ALAD) is one of the most sensitive indicators of blood lead levels. ALAD is polymorphic, with about 20% of Caucasians expressing the rarer ALAD2 allele. Previous studies indicated that this polymorphism may be a genetic factor in lead transport, metabolism, and/or distribution. Whole blood lead, serum lead, and ALAD genotype were determined for 381 lead smelter workers, including 70 workers expressing the ALAD2 allele, whose blood lead elevations were observed for more than 20 years of employment. The same employees demonstrated higher serum lead levels. Using a cumulative blood lead index (CBLI) for each worker, based on individual blood lead histories, and in vivo X-ray fluorescence measurements of bone lead to estimate total lead body burden, the slopes of linear relations of bone lead to CBLI were greater for workers homoallelic for ALAD1, indicating more efficient uptake of lead from blood into bone. This effect was most significant in calcaneus bone and for workers hired since 1977 [ALAD1-1: 0.0528 +/- 0.0028 and ALAD1-2 or 2-2: 0.0355 +/- 0.0031 (P < 0.001)]. Decreased transfer of blood lead into bone in individuals expressing the ALAD2 allele contrasted with increased blood lead. Thus the ALAD genotype affected lead metabolism and potentially modified lead delivery to target organs including the brain; however, the ALAD genotype did not significantly affect the net accumulation of lead in bone.

[1]  M. Mclaughlin,et al.  Effects of delta-aminolaevulinic acid on contractile activity in the isolated small intestine of the rabbit Role of adrenergic receptors , 1985, Neuropharmacology.

[2]  W. Trethowan,et al.  In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. , 1988, British journal of industrial medicine.

[3]  A. H. Marcus,et al.  Multicompartment kinetic model for lead. III. Lead in blood plasma and erythrocytes. , 1985, Environmental research.

[4]  J. Schwartz,et al.  The relationship between blood lead and blood pressure in the NHANES II survey. , 1988, Environmental health perspectives.

[5]  J. Robin,et al.  Accumulated body burden and endogenous release of lead in employees of a lead smelter. , 1997, Environmental health perspectives.

[6]  Howard Hu,et al.  Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone. , 1991, American journal of industrial medicine.

[7]  R. Desnick,et al.  Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. , 1991, American journal of human genetics.

[8]  M. Rabinowitz,et al.  Toxicokinetics of bone lead. , 1991, Environmental health perspectives.

[9]  P. Bogdański,et al.  Polymorphism of delta-aminolevulinic acid dehydratase in various populations. , 1983, Human heredity.

[10]  R Attewell,et al.  In vivo measurements of lead in bone in long-term exposed lead smelter workers. , 1993, Archives of environmental health.

[11]  S. Yannai,et al.  A multidisciplinary study of lead-exposed subjects. I. Delayed target detection P-300 latency, an electrophysiological parameter, correlates with urinary delta-ALA. , 1994, Environmental research.

[12]  J. Angerer,et al.  Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers , 1986, International archives of occupational and environmental health.

[13]  Y. Lolin,et al.  An Intra-Erythrocytic Low Molecular Weight Lead-Binding Protein in Acute and Chronic Lead Exposure and its Possible Protective Role in Lead Toxicity , 1988, Annals of clinical biochemistry.

[14]  W. Stewart,et al.  Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. , 1995, American journal of epidemiology.

[15]  L J Somervaille,et al.  Lead in bone: sampling and quantitation using K X-rays excited by 109Cd. , 1991, Environmental health perspectives.

[16]  P. Barry.  A comparison of concentrations of lead in human tissues. , 1975, British journal of industrial medicine.

[17]  U. Muller-eberhard,et al.  Pathophysiology of heme synthesis. , 1988, Seminars in hematology.

[18]  S. Hernberg,et al.  Enzyme inhibition by lead under normal urban conditions. , 1970, Lancet.

[19]  Howard Hu,et al.  Attentional correlates of dentin and bone lead levels in adolescents. , 1994, Archives of environmental health.

[20]  G. Battistuzzi,et al.  δ‐aminolevulinate dehydrase: a new genetic polymorphism in man , 1981, Annals of human genetics.

[21]  C. M. Smith,et al.  A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. , 1995, Environmental health perspectives.

[22]  P. Succop,et al.  The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. , 1993, Neurotoxicology and teratology.

[23]  C. Bulpitt,et al.  Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. , 1992, The New England journal of medicine.

[24]  S. Skerfving,et al.  Lead in finger-bone analysed in vivo in active and retired lead workers. , 1984, American journal of industrial medicine.

[25]  R. Desnick,et al.  δ‐Aminolevulinic Acid Dehydratase Isozymes and Lead Toxicity a , 1987 .

[26]  R. Desnick,et al.  The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. , 1991, Environmental research.

[27]  J. Wetmur.  Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden. , 1994, Environmental health perspectives.

[28]  E J O'Flaherty,et al.  Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans. , 1993, Toxicology and applied pharmacology.

[29]  Jari Erkkilä,et al.  In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure. , 1992, British journal of industrial medicine.